GPAT 2025 - Last Minute Revision Notes
1. PHARMACEUTICS
Important Formulas:
- First-order kinetics: Log C = Log C0 - kt/2.303
- Zero-order kinetics: C = C0 - kt
- Half-life (t½): First-order: 0.693/k | Zero-order: C0 / 2k
Key Topics:
- HLB scale: <10 = lipophilic, >10 = hydrophilic
- BCS classification (I - high/high, IV - low/low)
- Emulsions: Oil-in-water vs Water-in-oil
- Sterilization: Moist heat (121°C for 15 mins), Dry heat (160°C for 2 hrs)
- Isotonicity: E-value method, Liso method
2. PHARMACEUTICAL CHEMISTRY
SAR Highlights:
- Sulfonamides: -SO2NH2 essential for activity
- Quinolones: Fluoro group at position 6 enhances potency
- Beta-lactams: 4-membered lactam ring crucial
Tests:
- Aldehydes: Schiff's test
- Phenols: Ferric chloride test (violet color)
- Carboxylic acids: Sodium bicarbonate test (effervescence)
GPAT 2025 - Last Minute Revision Notes
Important Structures:
- Paracetamol, Aspirin, Sulfanilamide, Diazepam, Ciprofloxacin
3. PHARMACOLOGY
Receptors:
- Muscarinic: M1 (CNS), M2 (heart), M3 (glands)
- Adrenergic: Alpha1 (vasoconstriction), Beta2 (bronchodilation)
Important Drugs:
- ACE inhibitors: Captopril - dry cough ADR
- NSAIDs: Inhibit COX enzymes - gastric irritation
- Insulin types: Rapid (Lispro), Short (Regular), Long (Glargine)
Toxicology Mnemonics:
- SLUDGE: Salivation, Lacrimation, Urination, Defecation, GI upset, Emesis
- ABCD: Agitation, Blurred vision, Constipation, Dry mouth
4. PHARMACOGNOSY
Drug Sources:
- Atropa belladonna - Leaves - Tropane alkaloid
- Cinchona - Bark - Quinine (alkaloid)
- Digitalis - Leaves - Cardiac glycoside
GPAT 2025 - Last Minute Revision Notes
Tests:
- Alkaloids: Dragendorff's - orange ppt
- Glycosides: Keller-Killiani test - blue ring
- Tannins: Ferric chloride - blue/green ppt
Terms:
- Adulteration: Substitution, spoilage, deliberate
- Classification: Leaves (Senna), Roots (Ipecac)
5. NIPER & MISCELLANEOUS
Clinical Trials Phases:
- I: Safety (20-80), II: Efficacy (100-300)
- III: Large-scale (1000-3000), IV: Post-marketing
Biotech Keywords:
- rDNA: Insulin, Monoclonal antibodies: -mab (e.g., Trastuzumab)
ICH Guidelines:
- Q8: Pharmaceutical development
- Q9: Quality risk management
- Q10: Pharmaceutical quality system